PURE Bioscience (PURE) 10-Q2011 Q1 Quarterly report

Filed: 15 Dec 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Good

New words: accredited, agreed, API, Arab, athlete, calendar, candidate, categorize, chosen, compromised, Conditio, connection, consummated, Delaware, di, divested, domicile, duct, East, eleven, employed, erage, es, ethod, Exchan, exhibition, expectedly, final, finite, flective, foot, fu, ge, gy, iii, inancial, increa, increm, ing, le, lev, master, Middle, milestone, Municipality, nail, notice, nts, ompensation, ood, ou, poi, preclinical, predictor, privileg, pro, prominent, ransaction, region, reincorporate, reincorporation, reliance, request, requi, resale, resold, salary, satisfying, se, ss, stoc, technolo, tinea, torical, true, ture, umber, underwriter, unguium, variety

Removed: Advisory, affiliated, alternate, amending, Andrew, announced, antibacterial, antifungal, antiviral, Argentina, bad, blending, Buckland, Codification, collectively, Colombia, conformity, consultant, Costa, declared, deconsolidated, deconsolidation, deferral, delinquent, distributing, domestically, Donna, embedded, enable, enterprise, entirety, estate, exchanged, exercisable, expanded, expiration, extension, extremely, feature, February, fee, framework, gallon, hedge, higher, hundred, improve, indexed, intent, interpretive, investee, invoiced, joined, launch, literature, maximum, measurement, modified, nongovernmental, overhead, Panama, Panel, parent, performed, permitted, practice, proportion, prospectively, provision, quoted, ratified, readily, real, referenced, reflective, remeasured, renewal, Renshaw, restated, Rica, Rodman, scalable, senior, settlement, shelf, Singer, sufficiently, superseded, sustain, temporarily, termination, test, twenty, unexpectedly, unusual, Venezuela, venture, Vice, Washout, written

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

PURE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of PURE Bioscience (the “Company”) hereby certifies, to such officer’s knowledge, that:

(i)	the accompanying report on Form 10-Q of the Company for the fiscal quarter ended October 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(ii)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: December 15, 2010	By:	/s/ Michael L. Krall
		Michael L. Krall President / Chief Executive Officer (Principal Executive Officer)

This certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.